ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
NCT00466063
·
clinicaltrials.gov ↗
COMPLETED
Status
108
Enrollment
INDUSTRY
Sponsor class
Conditions
Anemia
Interventions
DRUG:
Deferasirox
Sponsor
Novartis Pharmaceuticals